Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology 2019-11-13
  2. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients 2016-11-01
  3. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs 2014-06-16

Studies

6 studies carry this tag.

Date range

2002 to 2019

Top journals

  • BioMed research international 1
  • Cells 1
  • Mechanisms of ageing and development 1
  • Neurobiology of aging 1
  • Science translational medicine 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cells 2019-11-13 Biomarkers

    Among mediators of inflammation, chemokines play a pivotal role in the neuroinflammatory process related to Alzheimer's disease (AD).

  2. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Science translational medicine 2016-11-01 Tau biomarkers

    β-Amyloid (Aβ) peptides are thought to be critically involved in the etiology of Alzheimer's disease (AD).

  3. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. BioMed research international 2014-06-16 Biomarkers

    Chronic neuroinflammation is now considered one of the major factors in the pathogenesis of Alzheimer's disease (AD).

  4. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2003-08-01 Risk genes beyond APOE

    Alzheimer's disease (AD) is characterized by a microglial-mediated inflammatory response elicited by extensive amyloid deposition in the brain.

  5. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Mechanisms of ageing and development 2002-03-01 Biomarkers

    Hypertension is a main risk factor for cerebrovascular disease, including vascular dementia.

  6. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2002-01-01 Biomarkers

    Chronic neuroinflammatory processes including glial activation may play a role in the pathogenesis of Alzheimer's disease (AD).

All topic tags with their study counts